Edition:
United Kingdom

JCR Pharmaceuticals Co Ltd (4552.T)

4552.T on Tokyo Stock Exchange

6,400JPY
2:39am BST
Change (% chg)

¥60 (+0.95%)
Prev Close
¥6,340
Open
¥6,320
Day's High
¥6,410
Day's Low
¥6,320
Volume
11,500
Avg. Vol
122,180
52-wk High
¥7,350
52-wk Low
¥4,260

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- March 18 Jun 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 2 2 2
(2) OUTPERFORM 4 4 5 4
(3) HOLD 3 2 2 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.00 2.00 2.11

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-19 7 22,410.40 23,600.00 21,500.00 --
Year Ending Mar-20 8 25,792.00 27,300.00 22,900.00 25,295.00
Year Ending Mar-21 8 27,955.60 30,300.00 24,300.00 27,647.20
Earnings (per share)
Year Ending Mar-19 8 111.28 133.10 95.20 --
Year Ending Mar-20 8 142.49 162.38 115.00 145.62
Year Ending Mar-21 8 179.26 224.00 139.30 182.07
LT Growth Rate (%) 1 29.66 29.66 29.66 43.08

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 5,472.00 5,346.00 126.00 2.30
Quarter Ending Dec-17 5,200.00 5,061.00 139.00 2.67
Quarter Ending Sep-17 5,300.00 5,801.00 501.00 9.45
Quarter Ending Mar-15 4,311.00 4,539.00 228.00 5.29
Quarter Ending Dec-14 3,950.00 4,160.95 210.95 5.34

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-19 22,410.40 -- -- -- --
Year Ending Mar-20 25,792.00 25,792.00 25,147.90 25,147.90 25,295.00
Year Ending Mar-21 27,955.60 27,955.60 28,446.70 28,446.70 27,647.20

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-19 -- -- -- --
Year Ending Mar-20 0 0 3 1
Year Ending Mar-21 0 0 2 1
Earnings